SCHEMBL3052008

SCHEMBL3052008

O=C(Cl)c1ccc(F)c([N+](=O)[O-])c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
ALOX15 P16050 1/20 0.40
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP2D6 P10635 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 2/20 0.38
TSHR P16473 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CDK2 P24941 1/20 0.36
FLT1 P17948 2/20 0.35
FLT4 P35916 2/20 0.35
KDR P35968 2/20 0.35
CYP3A4 P08684 1/20 0.35
HPGD P15428 1/20 0.35
FBP1 P09467 1/20 0.35
GRIN2D O15399 2/20 0.35
GRIN3B O60391 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3086799 0.86 ALDH1A1 (0.48) ALDH1A1ALOX15CYP1A2CYP2C19CYP2D6
SCHEMBL23647994 0.84 ALDH1A1 (0.41) ALDH1A1ALOX15CYP1A2CYP2C19KMT2A
SCHEMBL9078790 0.82 TSHR (0.44) ALDH1A1CYP1A2CYP2C19CYP2D6KMT2A
SCHEMBL27898207 0.81 ALDH1A1 (0.39) ALDH1A1ALOX15CYP1A2CYP2C19KMT2A
SCHEMBL28789360 0.81 KCNH2 (0.38) ALDH1A1CYP1A2CYP2C19CYP2D6KMT2A
SCHEMBL3126288 0.79 TSHR (0.46) ALDH1A1ALOX15CYP1A2CYP2C19CYP2D6
SCHEMBL28061957 0.79 ALDH1A1 (0.46) ALDH1A1CYP1A2CYP2C19CYP2D6KMT2A
SCHEMBL27622467 0.79 ITGB1 (0.50) ALDH1A1KMT2AMEN1MAPTHTT
SCHEMBL28801592 0.79 MAPT (0.44) ALDH1A1CYP1A2CYP2C19CYP2D6KMT2A
SCHEMBL9849650 0.77 ALDH1A1 (0.55) ALDH1A1ALOX15KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119613347-A Saflufenacil herb method for synthesizing amine 永农生物科学有限公司 2025-03-14 CN disclosed
US-9920002-B2 Methods for producing sulfonic acid diamides BASF SE (DE) 2018-03-20 US disclosed
US-20120310010-A1 Method for producing sulfonamides BASF SE (DE) 2012-12-06 US disclosed
CN-101351443-B Process for preparing sulfonamides BASF SE 2012-11-28 CN disclosed
CN-102740698-A Compounds and methods for kinase modulation and indications therefor PLEXXIKON INC 2012-10-17 CN disclosed
US-8263806-B2 Method for producing sulfonamides BASF SE (DE) 2012-09-11 US disclosed
US-20100228054-A1 Method for Producing Sulfonamides BASF SE (DE) 2010-09-09 US disclosed
US-20100222586-A1 Methods for Producing Sulfonic Acid Diamides BASF SE (DE) 2010-09-02 US disclosed
CN-101821233-A Method for producing sulfonic acid diamides BASF SE 2010-09-01 CN disclosed
CN-101351443-A Process for preparing sulfonamides BASF AG (DE) 2009-01-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222586-A1 Methods for Producing Sulfonic Acid Diamides CBR3, SQOR, SRM ALDH1A1 1357/4885ALOX15 2803/4885CYP1A2 954/4885
US-20100228054-A1 Method for Producing Sulfonamides STS, MSRB3, SQOR ALDH1A1 1345/4885ALOX15 1867/4885CYP1A2 207/4885
US-20120310010-A1 Method for producing sulfonamides MSRB3, STS, TST ALDH1A1 2610/4885ALOX15 3530/4885CYP1A2 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.